Foresta Group Holdings has received allowance from the USPTO for its US patent application covering its proprietary rosin and terpene production process, expected to protect its technology until at least 2041.
- USPTO allows Foresta’s rosin and terpene extraction patent
- Patent protection expected through June 2041 in the US
- Related patent applications filed in multiple global markets
- Strengthens Foresta’s IP portfolio and commercialisation strategy
- Supports sustainable wood processing technology leadership
US Patent Allowance Marks Milestone for Foresta’s Pine Chemical Technology
Foresta Group Holdings (ASX:FGH) has cleared a significant hurdle in protecting its proprietary pine chemical extraction technology, with the United States Patent and Trademark Office (USPTO) granting allowance for its patent application titled “Method of extraction”. This patent covers Foresta’s rosin and terpene production process, key components in a range of industrial products from adhesives to perfumes.
Once formally granted, the patent will secure Foresta’s exclusive rights in the US market through to at least 16 June 2041, although the final term may be adjusted by the USPTO. This milestone is the first allowance in Foresta’s initial patent family focused on rosin and terpene extraction, a core pillar of its renewable chemical manufacturing business.
Global Patent Strategy Extends Beyond US Borders
Foresta has also filed national phase patent applications in numerous other jurisdictions, including Australia, Brazil, Canada, China, Europe, Indonesia, Japan, South Korea, Mexico, Malaysia, New Zealand, the Philippines, and Thailand. This broad geographic coverage aligns with the company’s ambition to establish a global footprint in natural pine chemical production.
Alongside this patent family, Foresta holds a second family of patents related to producing torrefied wood pellets and briquettes, underscoring its diversified approach to sustainable wood processing technologies.
Patent Allowance Bolsters Foresta’s Competitive Position
The USPTO allowance enhances Foresta’s intellectual property portfolio, reinforcing its commercialisation strategy and competitive edge in renewable pine chemical markets. The company’s proprietary process leverages the tree’s own solvent chemicals to extract valuable rosin and terpenes, which feed into everyday industrial products such as inks, car tyres, and paints.
This development dovetails with Foresta’s ongoing efforts to advance its integrated biomass manufacturing ambitions, including the Kawerau project in New Zealand, where it has secured a long-term lease for its biomass facility site and continues to navigate operational challenges and funding requirements.
Bottom Line?
Foresta’s patent allowance in the US is a key step in protecting its renewable chemical innovations, setting the stage for potential licensing and market expansion.
Questions in the middle?
- When will the US patent be formally granted and what final term adjustments might apply?
- How will Foresta leverage its strengthened IP portfolio in commercial partnerships or licensing deals?
- What progress can be expected on patent filings and approvals in other major markets?